The announcement from the NIH's RECOVER project comes amid frustration from patients who've struggled for months or even years with sometimes-disabling health problems.

Researchers chasing long COVID cures are eager to learn whether the drug can offer similar benefits to millions suffering from pain, fatigue and brain fog months after infection.